Chinese official warns of drug-market crackdown; FDA wants more data on new Treanda use;

@FiercePharma: EMA says it's investigating Roche for possible shortcomings in pharmacovigilance. More | Follow @FiercePharma

> China's health minister says the government is reforming hospital procurement and cracking down on cozy relationships between doctors and pharmaceutical companies. Report | Report

> Indian generics maker Lupin says it's on track to launch 15 new generic products in the U.S. by the end of its fiscal year, including 8-10 contraceptives. Report

> FDA asked Teva Pharmaceutical Industries ($TEVA) for more data about its cancer drug Treanda as the agency reviews a new first-line indication for patients with non-Hodgkin's lymphoma. Report

> Tanzania Pharmaceutical Industries is spending 5 million euros ($6.48 million) on a new plant that will begin production in March, officials said. Report

> FDA has granted $2.7 million to back a study pitting the transplant drug Prograf against generic versions of the drug, to determine whether copies are as effective. Report

Medical Device News

 @FierceMedDev: Roche Dx is slashing jobs as it rethinks its diabetes business. More | Follow @FierceMedDev

 @MarkHFierce: Scientists can produce stem cells in great numbers from cadaver scalp tissue. More | Follow @MarkHFierce

 @DamianFierce: Japan's Sysmex is in talks to buy Dune Medical Devices for $200M, according to a report. More | Follow @DamianFierce

> Allegro celebrates encouraging early data for lung cancer test. Article

> Philips Healthcare soars in Q3. Item

Biotech News

 @FierceBiotech: Hirano bodies may block Alzheimer's-related cell death. More | Follow @FierceBiotech

 @JohnCFierce: So AstraZeneca and Ironwood are getting close. AZ pays $25M in cash, up to $125M in miles for China rights to linaclotide; sharing revenue. | Follow @JohnCFierce

 @RyanMFierce: e-Therapeutics (computer-enabled network pharmacology) has shelved a MRSA candidate to focus on cancer program. More (reg. req.) | Follow @RyanMFierce

> Abbott doubles down on ADC cancer drugs in $245M-plus Seattle Genetics pact. Report

> GSK taps stem cell discovery to spot heart threats early. Story

> Celgene wraps promising PhIII data on new multiple myeloma challenger. Article

Biotech Research News

> Australian scientists grow HIV antibodies in cow's milk. More

> A transplant anti-rejection treatment could be the next cancer drug. Article

> Pluristem's placental stem cells combat fibrosis in preclinical test. Story

> Scientists produced stem cells from cadaver scalp tissue. Item

Pharma Manufacturing News

> China's WuXi AppTec opens biologics plant. More

> Mexico's Neolpharma snags Pfizer Puerto Rico plant. News

> Mylan buying vertically integrated SMS oncology plant. Story

And Finally... Statin therapy may have another benefit--preventing esophageal cancer--according to a new a data analysis. Report

Suggested Articles

Dupixent has been posting strong sales growth for Sanofi, and now the drugmaker has a third FDA indication to keep the momentum going.

Novartis has found itself caught up in a controversy about ingredients shipped to Syria that critics say could have been used to make sarin gas. 

AbbVie made a major splash Tuesday with its proposed $63 billion buyout of Allergan. But analysts and investors were hardly impressed.